Ferring AB
12Patents
0Active
12Granted
33Portfolio score
Filing activity: Nov 8, 1977 → Jun 20, 1996
Most-cited patents
| Patent | Title | Area | Cited by | Status |
|---|---|---|---|---|
| US5482931A | Stabilized pharmaceutical peptide compositions | Human Necessities | 76 | Expired |
| US5596078A | Synthesis of cyclic peptides | Human Necessities | 47 | Expired |
| US5726287A | Synthesis of cyclic peptides | Human Necessities | 42 | Expired |
| US5500413A | Process for manufacture of 1-deamino-8-D-arginine vasopressin | Emerging Cross-Sectional Technologies | 32 | Expired |
| US5498598A | Composition for nasal administration of desmopressin | Human Necessities | 32 | Expired |
| US5674850A | High purity desmopressin produced in large single batches | Chemistry; Metallurgy | 23 | Expired |
| US4402942A | Oxytocin derivatives | Human Necessities | 14 | Expired |
| US5629146A | Method for detection of human papillomavirus (HPV) for diagnostic purposes | Emerging Cross-Sectional Technologies | 8 | Expired |
| US4148787A | Antidiuretically effective polypeptide and a process for preparing the same | Emerging Cross-Sectional Technologies | 8 | Expired |
| US5981170A | Peptides, artificial antigens and immunoassay kits | Chemistry; Metallurgy | 8 | Expired |
| US5459236A | Vasoactive vasotocin derivatives | Human Necessities | 5 | Expired |
| US4504469A | Vasotocin derivatives | Emerging Cross-Sectional Technologies | 4 | Expired |
Source: USPTO / EPO open patent data. Counts and citation impact are objective bibliographic measures.